| TIME | HALL A | TIME | HALL B |
| 14:00–17:00 | Hands-on Course A | 14:00–17:00 | Hands-on Course B |
| Topic to be announced | Topic to be announced | ||
| *Please note that course registration requires a fee. To register for any course, you must first complete your congress registration. | |||
| HALL A | HALL B | HALL C | |
| SESSION 1 – Gastroesophageal Reflux Disease | |||
| 09:00-09:15 | Barrett’s Esophagus in Non-Western Populations: Endoscopic Findings and Clinical Implications | ||
| 09:15-09:30 | PPI and PCAP Stewardship: Right Patient, Right Dose, Right Duration | ||
| 09:30-09:45 | Protecting Patients From Overtreatment in GERD: When Intervention Becomes Excess | ||
| 09:45-10:00 | Discussion | ||
| 10:00-10:20 | Good Morning Coffee & Tea Break | ||
| 10:20–10:45 | OPENING CEREMONY |
||
| PLENARY SESSION – Global South Gastroenterology: From Evidence to Implementation | |||
| 10:45–11:15 | Closing the Implementation Gap in Global South Gastroenterology | ||
| SESSION 2 –Upper GI Disorders, Dyspepsia & H. pylori | |||
| 11:15–11:30 | Test-and-Treat Strategies with Limited Endoscopy Access | ||
| 11:30–11:45 | Empirical Therapy vs Diagnostic Testing: Decision Thresholds | ||
| 11:45–12:00 | Antimicrobial Resistance without Susceptibility Testing | ||
| 12:00–12:15 | When Dyspepsia Persists: Moving Beyond Acid and Infection | ||
| 12:15–12:30 | Discussion | ||
| 12:30–13:30 | Lunch Break & Abstract Session | ||
| SATELLITE SYMPOSIUM 1 | |||
| 13:30–14:00 | Satellite Symposium – Industry Supported Session | ||
| 14:00-15:00 | CASE DISCUSSIONS – SESSION I (Parallel Rooms) | ||
| ROOM A – Common Biliary Emergencies • Cholangitis: Timing ERCP and Choosing Alternatives • Gallstone Pancreatitis: Making the Right Referral at the Right Time |
ROOM B – Upper Gastrointestinal & Functional Spectrum • Refractory GERD with & without High-Tech Tools • The EoE trap: Delayed Diagnosis in Routine Reflux Care |
ROOM C – Functional Bowel Disorders • IBS with Persistent Symptoms and Normal Tests • Constipation: Stopping Over-Investigation, Treat with Medicines or Biofeedback |
|
| SESSION 3 – IBD: Advanced Therapies & Real-World Positioning | |||
| 15:00–15:15 | Emerging Biologics and Small Molecules in IBD | ||
| 15:15–15:30 | Positioning New Agents Across Different Access Settings | ||
| 15:30–15:45 | IBD Care Interruptions in the Global South: How to Manage Gaps, Switches, and Restarts | ||
| 15:45-16:00 | Discussion | ||
| 16:00-16:15 | Coffee Break | ||
| SESSION 4 – Endoscopy & Nutrition | |||
| 16:15-16:30 | Artificial Intelligence in Endoscopy: Where it Truly Adds Value | ||
| 16:30-16:45 | What Experienced Endoscopists do Differently? | ||
| 16:45-17:00 | Malnutrition and Sarcopenia in GI Practice: Simple Screening Tools with Real Impact | ||
| 17:00-17:15 | Discussion | ||
| 17:15 | WORKING GROUPS | ||
| HALL A | HALL B | HALL C | |
| SESSION 5 – Hepatology & Metabolic Liver Disease | |||
| 09:00–09:15 | MAFLD Risk Stratification with or without Universal FibroScan | ||
| 09:15–09:30 | Albumin Revisited in Liver Disease: Old Drug, New Roles | ||
| 09:30–09:45 | Managing Cirrhosis Complications in Non-Transplant Centers | ||
| 09:45-10:00 | Prognostic Assessment in Advanced Liver Disease: When Aggressive Care No Longer Helps | ||
| 10:00–10:15 | Discussion | ||
| SATELLITE SYMPOSIUM 2 | |||
| 10:15–10:45 | Satellite Symposium – Industry Supported Session | ||
| 10:45-11:00 | Coffee Break | ||
| SESSION 6 –GI Oncology & Prevention | |||
| 11:00–11:15 | Gastric Cancer Epidemiology & Tailored Surveillance | ||
| 11:15–11:30 | Interval Colon Cancer in GI Practice: Why Screening Sometimes Fails | ||
| 11:30–11:45 | The Incidentaloma Dilemma: Avoiding Overdiagnosis Without Missing Cancer | ||
| 11:45–12:00 | Discussion | ||
| 12:00–13:00 | Lunch Break & Abstract Session | ||
| 13:00-14:00 | CASE DISCUSSIONS – SESSION II (Parallel Rooms) | ||
| ROOM A – Ano-Rectal Disorders: Common Symptoms, Difficult Diagnoses • Benign Anorectal Diseases: Navigating Common Symptoms without Oversimplification • Misleading Rectal Symptoms: Uncovering Solitary Rectal Ulcer Syndrome |
ROOM B – Advanced Hepatology Cases • Unexplained Liver Injury: When the Cause is the Prescription (DILI) • ACLF: Referral Thresholds |
ROOM C – IBD Under Constraints • Steroid Dependence with Delayed Biologic Access • IBD and infection Risk in High-Burden Regions |
|
| SATELLITE SYMPOSIUM 3 | |||
| 14:00–14:30 | Satellite Symposium – Industry Supported Session | ||
| 14:30-14:45 | Coffee Break | ||
| SESSION 7 – Pancreatic Disorders | |||
| 14:45–15:00 | Acute Pancreatitis: Early Risk Stratification in Real-World Settings | ||
| 15:00–15:15 | Pancreatic Exocrine Insufficiency: Looking Beyond the Pancreas | ||
| 15:15–15:30 | IPMN: Deciding Who to Surveil and Who to Intervene | ||
| 15:30–15:45 | Discussion | ||
| SESSION 8 –Bowel Disorders | |||
| 15:45–16:00 | Gut microbiota in functional GI disorders: what matters and what doesn’t | ||
| 16:00–16:15 | Biofeedback in Functional Bowel Disorders: Evidence, Expectations, and Outcomes | ||
| 16:15–16:30 | Fecal Incontinence: Mechanisms, Phenotypes, and Targeted Management | ||
| 16:30–16:45 | Discussion | ||
| CLOSING SESSION Closing Remarks & Regional Collaboration Roadmap |
|||
August
27thMay
1stJune
1st